Literature DB >> 11248065

ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma.

G H Su1, R Bansal, K M Murphy, E Montgomery, C J Yeo, R H Hruban, S E Kern.   

Abstract

DPC4 is known to mediate signals initiated by type beta transforming growth factor (TGFbeta) as well as by other TGFbeta superfamily ligands such as activin and BMP (bone morphogenic proteins), but mutational surveys of such non-TGFbeta receptors have been negative to date. Here we describe the gene structure and novel somatic mutations of the activin type I receptor, ACVR1B, in pancreatic cancer. ACVR1B has not been described previously as a mutated tumor-suppressor gene.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11248065      PMCID: PMC30640          DOI: 10.1073/pnas.051484398

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library.

Authors:  G H Su; T A Sohn; B Ryu; S E Kern
Journal:  Cancer Res       Date:  2000-06-15       Impact factor: 12.701

2.  Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.

Authors:  R E Wilentz; G H Su; J L Dai; A B Sparks; P Argani; T A Sohn; C J Yeo; S E Kern; R H Hruban
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

3.  Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.

Authors:  J Cárcamo; F M Weis; F Ventura; R Wieser; J L Wrana; L Attisano; J Massagué
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

4.  Distinct roles of the intracellular domains of transforming growth factor-beta type I and type II receptors in signal transduction.

Authors:  T Okadome; H Yamashita; P Franzén; A Morén; C H Heldin; K Miyazono
Journal:  J Biol Chem       Date:  1994-12-09       Impact factor: 5.157

5.  Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression.

Authors:  R E Wilentz; C A Iacobuzio-Donahue; P Argani; D M McCarthy; J L Parsons; C J Yeo; S E Kern; R H Hruban
Journal:  Cancer Res       Date:  2000-04-01       Impact factor: 12.701

6.  Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.

Authors:  M Goggins; M Shekher; K Turnacioglu; C J Yeo; R H Hruban; S E Kern
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

7.  Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.

Authors:  S Markowitz; J Wang; L Myeroff; R Parsons; L Sun; J Lutterbaugh; R S Fan; E Zborowska; K W Kinzler; B Vogelstein
Journal:  Science       Date:  1995-06-02       Impact factor: 47.728

8.  p53 Mutation and MDM2 amplification in human soft tissue sarcomas.

Authors:  F S Leach; T Tokino; P Meltzer; M Burrell; J D Oliner; S Smith; D E Hill; D Sidransky; K W Kinzler; B Vogelstein
Journal:  Cancer Res       Date:  1993-05-15       Impact factor: 12.701

9.  Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma.

Authors:  C Caldas; S A Hahn; L T da Costa; M S Redston; M Schutte; A B Seymour; C L Weinstein; R H Hruban; C J Yeo; S E Kern
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

10.  GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex.

Authors:  R Wieser; J L Wrana; J Massagué
Journal:  EMBO J       Date:  1995-05-15       Impact factor: 11.598

View more
  43 in total

Review 1.  Molecular signatures of pancreatic cancer.

Authors:  Seung-Mo Hong; Jason Y Park; Ralph H Hruban; Michael Goggins
Journal:  Arch Pathol Lab Med       Date:  2011-06       Impact factor: 5.534

2.  Frequent loss of heterozygosity on chromosome 12q in non-small-cell lung carcinomas.

Authors:  Xiao-Jie Ding; Min-Xia Liu; Lei Ao; Yi-Rong Liang; Yi Cao
Journal:  Virchows Arch       Date:  2011-01-29       Impact factor: 4.064

Review 3.  Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.

Authors:  Andrew D Rhim; Ben Z Stanger
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

4.  Loss of ACVRIB leads to increased squamous cell carcinoma aggressiveness through alterations in cell-cell and cell-matrix adhesion proteins.

Authors:  Holli A Loomans; Shanna A Arnold; Kate Hebron; Chase J Taylor; Andries Zijlstra; Claudia D Andl
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

5.  A kinase shRNA screen links LATS2 and the pRB tumor suppressor.

Authors:  Katrin Tschöp; Andrew R Conery; Larisa Litovchick; James A Decaprio; Jeffrey Settleman; Ed Harlow; Nicholas Dyson
Journal:  Genes Dev       Date:  2011-04-15       Impact factor: 11.361

Review 6.  The pancreatic cancer genome revisited.

Authors:  Akimasa Hayashi; Jungeui Hong; Christine A Iacobuzio-Donahue
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-04       Impact factor: 46.802

7.  Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin.

Authors:  Barbara H Jung; Stayce E Beck; Jennifer Cabral; Eddy Chau; Betty L Cabrera; Antonio Fiorino; E Julieta Smith; Melanie Bocanegra; John M Carethers
Journal:  Gastroenterology       Date:  2006-11-16       Impact factor: 22.682

Review 8.  Activin receptor-like kinases: a diverse family playing an important role in cancer.

Authors:  Holli A Loomans; Claudia D Andl
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

Review 9.  Pancreatic carcinogenesis.

Authors:  Jan-Bart M Koorstra; Steven R Hustinx; G Johan A Offerhaus; Anirban Maitra
Journal:  Pancreatology       Date:  2008-04-01       Impact factor: 3.996

10.  Activin signaling as an emerging target for therapeutic interventions.

Authors:  Kunihiro Tsuchida; Masashi Nakatani; Keisuke Hitachi; Akiyoshi Uezumi; Yoshihide Sunada; Hiroshi Ageta; Kaoru Inokuchi
Journal:  Cell Commun Signal       Date:  2009-06-18       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.